Does FILGRASTIM Cause Hormone-refractory prostate cancer? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hormone-refractory prostate cancer have been filed in association with FILGRASTIM (NYPOZI txid). This represents 0.1% of all adverse event reports for FILGRASTIM.
8
Reports of Hormone-refractory prostate cancer with FILGRASTIM
0.1%
of all FILGRASTIM reports
5
Deaths
0
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From FILGRASTIM?
Of the 8 reports, 5 (62.5%) resulted in death, and 2 (25.0%) were considered life-threatening.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
BICALUTAMIDE (50)
Which FILGRASTIM Alternatives Have Lower Hormone-refractory prostate cancer Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE